<DOC>
	<DOCNO>NCT01504659</DOCNO>
	<brief_summary>The investigator plan evaluate efficacy safety intranasal Ketalar ( ketamine hydrochloride ) treatment primary symptom manifestation pediatric bipolar disorder ; Fear Harm ( FOH ) phenotype . This phenotype represent child resistant traditional treatment suffer repeated hospitalization . Primary symptom include fearfulness , aggression secondary threat , mood and/or arousal instability , psychosis . In addition evaluation efficacy safety , investigator also analyze whether therapeutic response depend upon degree subject fit FOH phenotype .</brief_summary>
	<brief_title>Intranasal Ketamine In Treatment Pediatric Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . Males female age 612 ; 2 . DSMIV bipolar disorder ( BPI , BPII , BPNOS , BPFOH ) ; 3 . Treatment resistant defined failure adequately respond least 2 different class medication mood stabilizer antipsychotic agent . 1 . Contraindication use ketamine , include allergy current use medicine contraindicate ketamine ; 2 . Endocrine neurological illness ; 3 . Previous history close head injury , current head injury associate possible intracranial hypertension , central nervous system mass , abnormality , hydrocephalus , ever loss consciousness ; 4 . Previous history glaucoma acute globe injury 5 . Abnormal nasal physiology would allow adequate medication delivery ; 6 . Any change medication type dose within past 30 day ; 7 . Treatment MAOI 's currently within past 3 month ; 8 . Has course ECT within past 3 month ; 9 . Has ever use PCP ketamine ; 10 . Meets DSMIV criterion Mental Retardation ; 11 . Has ever Repetitive Transcranial Magnetic Stimulation ( rTMS ) , Vagal Nerve Stimulation ( VNS ) Deep Brain Stimulation ; 12 . Is currently hospitalize ; 13 . Has know suspect schizophrenia , even currently stable control medication 14 . Is acutely suicidal homicidal ( i.e. , imminent danger plan , urges intent harm oneself others ) include serious attempts/those require hospitalization past 12 month PI 's discretion ; 15 . The presence abnormal laboratory finding serious medical disorder condition include : clinically significant organ system dysfunction ; significant endocrine disease , include diabetes mellitus ; hypothyroidism ; cardiovascular disease ( myocardial ischemia , heart failure , arrhythmia ) ; coagulopathy ; significant anemia ; significant acute infection ; glaucoma ; dehydration ; epilepsy ; intraabdominal intrathoracic surgery limb amputation within prior 6 month ; diagnose cardiac condition cause document hemodynamic compromise dysfunction SA AV node ; diagnose respiratory condition cause document clinically recognize hypoxia ( e.g. , chronic obstructive restrictive pulmonary disease ) ; body weight approximately &lt; 80 % &gt; 120 % ideal body weight ; medical condition know interfere cognitive performance ; medicationrelated exclusion include narcotic therapy , chronic acetaminophen use , acute sedative hypnotic withdrawal , corticosteroid spironolactone therapy , regularly dose narcotic sedative therapy medication interfere SA AV node function could consider contraindicated sedative property ketamine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>treatment resistance</keyword>
	<keyword>depression</keyword>
	<keyword>ketamine</keyword>
	<keyword>intranasal</keyword>
	<keyword>child</keyword>
</DOC>